Table 2 1H NMRa (δ) and 31P-{1H} NMR datab (δ) for compounds 1b–6
Compound
31P
1H
1b
1c
44.1
7.8–7.3 (br m, 12H, aryl H), 6.9 (dd, JHH 8.5, JPH 2.1, 2H, aryl H), 5.9 (br s, 1H, OH).
7.8–7.7 (br m, 4H, aryl H), 7.6–7.3 (br m, 8H, aryl H), 6.8 (dd, JHH 7.5, JPH 2.0, 2H, aryl H), 5.8 (br s, 1H,
OH).
35.4 (1JP–Se 712.1)
2a
2b
2c
2d
2e
2f
42.8
13.3 (s, 1H, OH), 8.3 (dd, JPH 13.6, JHH 1.9, 1H, aryl H), 7.9–7.3 (br m, 16H, aryl H), 7.1 (dd, JHH 8.6, JHH
2.5, 1H, aryl H).
42.8
13.4 (s, 1H, OH), 8.3 (dd, JPH 15.7, JHH 2.2, 1H, aryl H), 7.9–7.3 (br m, 15H, aryl H), 7.1 (dd, JHH 8.6, JHH
2.5, 1H, aryl H), 5.29 (s, ¹ H, CH2Cl2), 2.4 (s, 3H, CH3).
¯
²
42.9
13.4 (s, 1H, OH), 8.3 (dd, JPH 13.6, JHH 2.1, 1H, aryl H), 7.8–7.2 (br m, 15H, aryl H), 7.1 (dd, JHH 8.6, JHH
2.7, 1H, aryl H), 2.7 (q, JHH 7.2, 2H, CH2), 1.3 (t, JHH 7.2, 3H, CH3).
42.9
13.4 (s, 1H, OH), 8.3 (dd, JPH 15.7, JHH 2.3, 1H, aryl H), 7.8–7.3 (br m, 15H, aryl H), 7.1 (dd, JHH 8.6, JHH
2.7, 1H, aryl H), 3.0 (m, JHH 7.0, 1H, CH), 1.3 (d, JHH 7.0, 6H, CH3).
13.4 (s, 1H, OH), 7.8 (dd, JPH 14.7, JHH 2.1, 1H, aryl H), 7.7–7.3 (br m, 15H, aryl H), 7.1 (dd, JHH 8.5, JHH
2.5, 1H, aryl H), 1.6 (s, 9H, CH3).
42.9
43.7
13.7 (s, 1H, OH), 8.2 (dd, JPH 13.8,JHH 2.0, 1H, aryl H), 7.8–7.5 (br m, 13H, aryl H), 7.0 (dd, JHH 8.5, JHH
3.0, 1H, aryl H), 6.7 (dd, JHH 8.5, JHH 3.0, 1H, aryl H), 3.1 (s, 6H, CH3).
2g
2h
2i
43.2
12.9 (s, 1H, OH), 8.4–8.3 (br m, 3H, aryl H), 8.0 (d, JHH 8.5, 2H, aryl H), 7.8–7.5 (br m, 1014 H, aryl H,
14 CHCl ), 7.1 (dd, JHH 8.7, JHH 2.8, 2H, aryl H).
35.2 (1JP–Se 731.7)
35.2 (1JP–Se 732.7)
13.4 (s, 31H, OH), 8.3 (dd, JPH 13.8, JHH 2.0, 1H, aryl H), 7.8–7.5 (br m, 15H, aryl H), 7.1 (dd, JHH 8.5, JHH
2.5, 1H, aryl H), 5.29 (s, 13 H, CH Cl ).
13.4 (s, 1H, OH), 8.3 (dd, JPH 14.20, 2JHH 2.0, 1H, aryl H), 7.8–7.7 (br m, 7H, aryl H), 7.5–7.4 (br m, 5H,
1
4
aryl H), 7.3 (d, JHH 8.5, 1H, aryl H), 7.1 (dd, JHH 8.7, JHH 2.6, 1H, aryl H), 5.29 (s, H, CH2Cl2), 2.4
(s, 3H, CH3).
3
4a
4b
44.5
37.9
37.9
7.8–7.9 (br m, 4H, aryl H), 7.6–7.5 (br m, 7H, aryl H), 7.3–7.2 (br m, 3H, aryl H).
14.2 (s, 1H, OH), 8.0–7.9 (br m, 6H, aryl H), 7.4–7.2 (br m, 16H, aryl H).
14.2 (s, 1H, OH), 8.0–7.9 (br m, 5H, aryl H), 7.8–7.0 (br m, 15H, aryl H), 2.36 (s, 3H, CH3), 2.355 (s, 3H,
CH3).
4c
37.8
38.0
14.3 (s, 1H, OH), 8.0–7.7 (br m, 8H, aryl H), 7.7–7.0 (br m, 7H, aryl H), 6.5–6.4 (br m, 5H, aryl H), 3.06
(s, 6H, CH3), 3.04 (s, 6H, CH3).
4d
5
14.0 (s, 1H, OH), 8.2–7.9 (br m, 10H, aryl H), 7.4–7.2 (br m, 10H, aryl H), 5.29 (s, ¹ H, CH2Cl2).
¯
²
7.77 (d, JHH 9.0, 2H, aryl H), 7.65 (d, JHH 9.0, 1H, aryl H), 7.29 (d, JHH 9.0, 2H, aryl H), 6.7 (m, 2H, aryl
H), 5.1 (s, 1H, OH), 2.7 (s, 3H, CH3), 2.42 (s, 3H, CH3).
6
14.4 (s, 1H, OH), 7.8 (m, 5H, CH), 7.3 (m, 4H, CH), 6.9 (d, JHH 9.0, 1H, CH), 3.1 (s, 3H, CH3), 2.45
(s, 3H, CH3), 2.44 (s, 3H, CH3).
a Spectra recorded in CDCl3 (293 K) and referenced to CHCl3; coupling constants in Hz. b Spectra recorded in CDCl3 (293 K) and referenced to 85%
H3PO4; coupling constants in Hz.
Fig. 7 Representation of the rotation about P–C bond observed in
molecular structure of 4b.
Fig. 6 ORTEP representation of compound 4b showing the atomic
substitution at the sterically least hindered site ortho to the
numbering scheme.
hydroxy group, since the ortho-effect should no longer be
operating.
evident that there is a strong hydrogen bond14 present in the
molecule: O(1)–H ؒ ؒ ؒ N(2) with O(1)–H 0.753(2), O(1)–N(2)
2.578(2), N(2)–H 1.994(2) Å, O–H–N 134.6(11) which is
common in these types of compounds.15 Since 4b contains two
azo-moieties, of which only one is ortho to the hydroxy group,
direct structural evidence for the presence of hydroxyazo–
ketohydrazone tautomerisation in phenol based systems should
be possible.15 Unfortunately in the crystal, rotation about the
P(1)–C(3) bond, Fig. 7, was evident about 20% of the time
which means that the bond lengths around each azo-moiety in
the final structural model contain a contribution from both
types of azo environment and so no such interpretation can be
made.
Since the coupling reaction of 3 with diazonium salts had
occurred at the expected ortho-positions to the meta-directing
Ph2PS group, we were curious as to whether replacing the
Ph2PS moiety with the formally ortho/para-directing methyl
group, and carrying the reaction out under identical conditions
would lead to (i) exclusively mono-substitution para to the
hydroxy group and (ii) on reaction of a second equivalent to
Treatment of m-cresol with a stoichiometric amount of NaH
in THF led to effervescence and the generation of the phen-
oxide ion, which on cooling to 0–5 ЊC and addition of [4-Me-
PhN᎐N][BF ] led exclusively, as expected, to formation of
᎐
4
1-HO-3-CH -4-(4-Me-PhN᎐N)-C H 5, i.e. the para-coupled
᎐
3
6
3
product and no evidence for any ortho-coupled product either
at the 2- or 6-position was obtained, Scheme 3, see Tables 1–3
for characterising data. Treatment of 5 with a stoichiometric
amount of NaH followed by [4-Me-PhN᎐N][BF ] led to the
isolation of the brown solid 1-HO-3-CH -2,4-(4-Me-PhN᎐N)-
C6H2 6 where a second coupling reaction had occurred and
once again exclusively in the sterically most congested ortho-
position; Scheme 3, see Tables 1–3 for characterising data. The
second coupling in the 2-position is clear from the proton
NMR spectrum by the presence of a doublet at 6.9 ppm JHH 9.0
Hz (the other expected doublet is obscured under the multiplet
centred at 7.32 ppm), whereas if coupling had occurred in the
6-position lower frequency long range coupling would of been
evident for the two protons on the substituted ring: no evidence
for this product was seen in the crude 1H NMR spectrum. This
᎐
4
᎐
3
2672
J. Chem. Soc., Perkin Trans. 1, 2001, 2669–2675